Final Agenda:

Download workshop booklet

Wednesday, September 7
12:00 pm Arrival at Axiogenesis Headquarter / LUNCH
01:05 pm Felix von Haniel
“Welcome/ Overview”
01:25 pm Dr. Stefan Mann (Cytocentrics / Victor Chang Cardiac Research Institute)
“SIDS and modulation of INaL by hypoxia, investigated in iPSC derived cardiomyocytes”
01:50 pm Dr. Marc Rogers (Metrion)
“Validating in vitro cardiac ion channel assays and screening platforms with human iPS cell-derived cardiomyocytes for improved prediction of clinical pro-arrhythmia risk”
02:20 pm Dr. Benjamin Bader (Neuroproof)
“Functional electrophysiological phenotyping of human iPSC-derived neurons grown on MEAs – a novel approach for in vitro disease modeling of neurodegenerative diseases”
02:40 pm Coffee break
03:30 pm Live Demonstrations

 

07:00 pm Dinner
Thursday, September 8
08:45 am Arrival at Axiogenesis Headquarter
09:05 am Dr. Dietmar Hess (Axiogenesis)
“Neural news: insights into Axiogenesis’ expanded neural product portfolio“
09:30 am Dr. Lia Scarabottolo (Axxam)
”Use of iPSC-derived cells in HTS. Still a dream or reality?”
09:55 am Dr. Hua Rong Lu (Janssen Pharmacauticals)
“Human stem cell research for drug-induced cardiac and neuronal safety / toxicities: Global Safety Pharmacology’s ongoing strategy”
10:20 am Coffee Break
10:50 am Dr. Greg Luerman (Axiogenesis)
“Case Studies in Cardiac Safety / Toxicity Assessment Using Human iPSC-Derived Cell Systems”
11:15 am Dr. Richard Printemps (Physiostim)
“Human induced pluripotent stem cells derived Cor.4U® ventricular cardiomyocytes (hiPSC-CM) as a predictive tool for preclinical safety assessment”
11:40 am Dr. Elena Dragicevic (Nanion Technologies)
“Electrophysiology in iPSC-derived neurons and cardiomyocytes: Microelectrode Array (MEA), optogenetics and automapted patch clamp approaches”
12:00 pm Lunch Break
01:00 pm Heribert Bohlen (Axiogenesis)
KEYNOTE: “From vision to reality: ipsc-derived cells in drug development”
01:25 pm Dr. Paul Walker (Cyprotex)
“Confocal high content screening of cardiac microtissues for the improved prediction of drug induced structural cardiotoxicity”
01:50 pm Dr. Denise Franz (University of Rostock)
“Electrophysiological characterization of human induced pluripotent stem cell-derived dopaminergic neurons using manual and automated patch clamp systems ”
02:15 pm Dr. Ian Hayes (Luxcel Biosciences Ltd.)
“Assessing the impact of drug treatment on cardiomyocyte function through combined analysis of beating, metabolic flux and cellular oxygenation”
02:40 pm Coffee Break
03:30 pm Live Demonstrations

 

04:45 pm Shuttle Bus to Hotel

 

Friday, September 9
08:45 am Arrival at Axiogenesis Headquarter
09:05 am Dr. Vincent Milleret (Ectica Technologies)
“iPSC-derived neural cultures in 3DProSeed hydrogel well plates”
09:25 am Dr. Francesco Pasqualini (Wyss Translational Center, University and ETH Zurich)
“Quality assurance systems in cell-based drug discovery and regenerative medicine”
09:50 am Dr. Stephane Bedut (Servier)
“Human iPSC-derived cardiomyocytes voltage and calcium signal recording with the Hamamatsu FDSS for drugs and cell lines characterization“
10:10 am Coffee Break
10:40 am Live Demonstrations
12:00 am Departure

 

 

Wet Lab Demos:

Cytotox / Mitotox Assay

Multi Electrode Array

Impedance

Optogenetics

HTS Calcium / Voltage Sensitive Dyes

Cardiac Cell Contractile Force Measurement